Some studies support that CDKN2A/2BDEL, especially in the case of biallelic status, is associated with inferior outcomes in B-ALL (16–18), while others claim that this alteration is not a poor prognostic factor in childhood B-ALL (14, 19). Here, CDKN2A is linked to acute lymphoblastic leukemia.